1 1853 135 RANDOMISED CLINICAL TRIAL: YOGA VS WRITTEN SELF-CARE ADVICE FOR ULCERATIVE COLITIS. BACKGROUND: PERCEIVED STRESS SEEMS TO BE A RISK FACTOR FOR EXACERBATION OF ULCERATIVE COLITIS. YOGA HAS BEEN SHOWN TO REDUCE PERCEIVED STRESS. AIMS: TO ASSESS THE EFFICACY AND SAFETY OF YOGA FOR IMPROVING QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS. METHODS: A TOTAL OF 77 PATIENTS (75% WOMEN; 45.5 +/- 11.9 YEARS) WITH ULCERATIVE COLITIS IN CLINICAL REMISSION BUT IMPAIRED QUALITY OF LIFE WERE RANDOMLY ASSIGNED TO YOGA (12 SUPERVISED WEEKLY SESSIONS OF 90 MIN; N = 39) OR WRITTEN SELF-CARE ADVICE (N = 38). PRIMARY OUTCOME WAS DISEASE-SPECIFIC QUALITY OF LIFE (INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE). SECONDARY OUTCOMES INCLUDED DISEASE ACTIVITY (RACHMILEWITZ CLINICAL ACTIVITY INDEX) AND SAFETY. OUTCOMES WERE ASSESSED AT WEEKS 12 AND 24 BY BLINDED OUTCOME ASSESSORS. RESULTS: THE YOGA GROUP HAD SIGNIFICANTLY HIGHER DISEASE-SPECIFIC QUALITY OF LIFE COMPARED TO THE SELF-CARE GROUP AFTER 12 WEEKS (DELTA = 14.6; 95% CONFIDENCE INTERVAL=2.6-26.7; P = 0.018) AND AFTER 24 WEEKS (DELTA = 16.4; 95% CONFIDENCE INTERVAL=2.5-30.3; P = 0.022). TWENTY-ONE AND 12 PATIENTS IN THE YOGA GROUP AND IN THE SELF-CARE GROUP, RESPECTIVELY, REACHED A CLINICAL RELEVANT INCREASE IN QUALITY OF LIFE AT WEEK 12 (P = 0.048); AND 27 AND 17 PATIENTS AT WEEK 24 (P = 0.030). DISEASE ACTIVITY WAS LOWER IN THE YOGA GROUP COMPARED TO THE SELF-CARE GROUP AFTER 24 WEEKS (DELTA = -1.2; 95% CONFIDENCE INTERVAL=-0.1-[-2.3]; P = 0.029). THREE AND ONE PATIENT IN THE YOGA GROUP AND IN THE SELF-CARE GROUP, RESPECTIVELY, EXPERIENCED SERIOUS ADVERSE EVENTS (P = 0.317); AND SEVEN AND EIGHT PATIENTS EXPERIENCED NONSERIOUS ADVERSE EVENTS (P = 0.731). CONCLUSIONS: YOGA CAN BE CONSIDERED AS A SAFE AND EFFECTIVE ANCILLARY INTERVENTION FOR PATIENTS WITH ULCERATIVE COLITIS AND IMPAIRED QUALITY OF LIFE. TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIER: NCT02043600. 2017 2 1717 60 PERCEIVED STRESS MEDIATES THE EFFECT OF YOGA ON QUALITY OF LIFE AND DISEASE ACTIVITY IN ULCERATIVE COLITIS. SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: YOGA POSITIVELY AFFECTS HEALTH-RELATED QUALITY OF LIFE AND DISEASE ACTIVITY IN ULCERATIVE COLITIS. THE UNDERLYING MODES OF ACTION REMAIN UNCLEAR. WITHIN THE PRESENT STUDY WE HYPOTHESIZED THAT PATIENTS PERCEIVED STRESS MEDIATES THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE AND DISEASE ACTIVITY. METHODS: THIS IS A SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFECTS OF YOGA TO WRITTEN SELF-CARE ADVICE IN PATIENTS WITH INACTIVE ULCERATIVE COLITIS AND IMPAIRED QUALITY OF LIFE. PERCEIVED STRESS WAS ASSESSED USING THE PERCEIVED STRESS QUESTIONNAIRE, HEALTH-RELATED QUALITY OF LIFE USING THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE AND DISEASE ACTIVITY USING THE CLINICAL ACTIVITY INDEX. OUTCOMES WERE ASSESSED AT WEEKS 0, 12 AND 24. RESULTS: SEVENTY-SEVEN PATIENTS PARTICIPATED. THIRTY-NINE PATIENTS ATTENDED THE 12 SUPERVISED WEEKLY YOGA SESSIONS (71.8% WOMEN; 45.0 +/- 13.3 YEARS) AND 38 PATIENTS WRITTEN SELF-CARE ADVICE (78.9% WOMEN; 46.1 +/- 10.4 YEARS). PERCEIVED STRESS CORRELATED SIGNIFICANTLY WITH HEALTH-RELATED QUALITY OF LIFE AND DISEASE ACTIVITY AT WEEK 24. PERCEIVED STRESS AT WEEK 12 FULLY MEDIATED THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE (B = 16.23; 95% CONFIDENCE INTERVAL [6.73; 28.40]) AND DISEASE ACTIVITY (B = -0.28; 95% CONFIDENCE INTERVAL [-0.56; -0.06]) AT WEEK 24. CONCLUSION: OUR FINDINGS CONFIRM THE IMPORTANCE OF PERCEIVED STRESS IN REDUCING DISEASE ACTIVITY AND INCREASING HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS AND IMPAIRED QUALITY OF LIFE. PRACTITIONERS SHOULD KEEP PSYCHOSOCIAL RISK IN MIND AS A RISK FACTOR FOR DISEASE EXACERBATION, AND CONSIDER YOGA AS AN ADJUNCT INTERVENTION FOR HIGHLY STRESSED PATIENTS WITH ULCERATIVE COLITIS. CLINICALTRIALS. GOV REGISTRATION NUMBER: THE TRIAL WAS REGISTERED AT CLINICALTRIALS.GOV PRIOR TO PATIENT RECRUITMENT (REGISTRATION NUMBER NCT02043600). 2020 3 1883 23 REDUCING PSYCHOLOGICAL DISTRESS AND OBESITY THROUGH YOGA PRACTICE. BACKGROUND: YOGA PRACTICE HAS BEEN EFFECTIVELY PRESCRIBED IN CONJUNCTION WITH OTHER MEDICAL AND YOGIC PROCEDURES IN THE MANAGEMENT OF SEVERE PSYCHOSOMATIC DISEASES, INCLUDING CANCER, BRONCHIAL ASTHMA, COLITIS, PEPTIC AND ULCER. IT IMPROVES STRENGTH AND FLEXIBILITY, AND MAY HELP CONTROL PHYSIOLOGICAL VARIABLES SUCH AS BLOOD PRESSURE, LIPIDS, RESPIRATION, HEART RATE, AND METABOLIC RATE TO IMPROVE OVERALL EXERCISE CAPACITY. AIM OF THE STUDY: THE AIM OF THIS STUDY IS TO EVALUATE THE EFFECTS OF YOGIC PRACTICE ON ANXIETY/DEPRESSION ASSOCIATED WITH OBESITY. MATERIALS AND METHODS: PATIENTS WERE RECRUITED FROM THE DEPARTMENT OF PHYSIOLOGY, C.S.M. MEDICAL UNIVERSITY (ERSTWHILE KGMU), LUCKNOW, UTTAR PRADESH, INDIA. A TOTAL OF 272 SUBJECTS WERE DIVIDED INTO TWO GROUPS: 1) GROUP OF 205 SUBJECTS (WITH YOGIC PRACTICE) AND 2) A CONTROL GROUP OF 67 SUBJECTS (WITH AEROBIC EXERCISE). ASSESSMENT OF ANXIETY AND DEPRESSION WERE DONE BY HAMILTON RATING SCALE. RESULT: THIS STUDY SUPPORTS YOGA AS AN EFFECTIVE TOOL WITH NO DIET RESTRICTION TO IMPROVE ANXIETY AND DEPRESSION SYMPTOMS AS WELL AS OBESITY IN OBESE SUBJECTS CONCLUSION: INCORPORATING YOGIC ASANA IN THE TREATMENT PROTOCOL OF PATIENTS SUFFERING FROM ANXIETY AND DEPRESSION MAY PROVE BENEFICIAL IN THE LONG RUN. 2013 4 891 42 EFFECT OF YOGA-BASED INTERVENTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. BACKGROUND: INFLAMMATORY BOWEL DISEASE (IBD) IS A CHRONIC ILLNESS CHARACTERIZED BY GROSS INFLAMMATION IN THE GASTROINTESTINAL TRACT THAT CAN RESULT IN SYMPTOMS SUCH AS ABDOMINAL PAIN, CRAMPING, DIARRHEA, AND BLOODY STOOLS. IBD IS BELIEVED TO BE INFLUENCED BY PSYCHOLOGICAL FACTORS SUCH AS STRESS AND ANXIETY. THEREFORE, A YOGA INTERVENTION THAT REDUCES STRESS AND ANXIETY MAY BE AN EFFECTIVE COMPLEMENTARY TREATMENT FOR THESE DISORDERS. MATERIAL AND METHODS: A TOTAL OF 100 IBD PATIENTS [ULCERATIVE COLITIS (UC) N = 60 AND CROHN'S DISEASE (CD) N = 40] DURING THE CLINICAL REMISSION PHASE OF DISEASE WERE INCLUDED IN THE STUDY. THESE PATIENTS WERE ALLOCATED RANDOMLY TO EITHER THE YOGA GROUP THAT UNDERWENT AN 8-WEEK YOGA INTERVENTION (PHYSICAL POSTURES, PRANAYAMA, AND MEDITATION) 1- HOUR/DAY IN ADDITION TO STANDARD MEDICAL THERAPY (UC, N = 30; CD, N = 20) OR THE CONTROL GROUP (UC, N = 30; CD N = 20), WHICH CONTINUED WITH STANDARD MEDICAL THERAPY ALONE. THE MAIN OUTCOME MEASURES WERE CARDIOVASCULAR AUTONOMIC FUNCTIONS, SERUM EOSINOPHILIC CATIONIC PROTEIN, INTERLEUKIN- 2 SOLUBLE RECEPTORS, SPEILBERGER'S STATE TRAIT ANXIETY INVENTORY (STAI) SCORES, AND CLINICAL SYMPTOMS. RESULTS: BEFORE THE INTERVENTION, ALL THE OUTCOME MEASURES WERE COMPARABLE IN THE TWO GROUPS. AFTER THE 8-WEEK YOGA INTERVENTION, FEWER UC PATIENTS REPORTED ARTHRALGIA. THE NUMBER OF PATIENTS REPORTING INTESTINAL COLIC PAIN IN THE CONTROL GROUP WAS HIGHER. STATE AND TRAIT ANXIETY LEVELS WERE SIGNIFICANTLY REDUCED IN PATIENTS WITH UC. HOWEVER, NO SIGNIFICANT CHANGES WERE OBSERVED IN CARDIOVASCULAR AUTONOMIC FUNCTIONS, EOSINOPHILIC CATIONIC PROTEINS, OR INTERLEUKIN-2 SOLUBLE RECEPTORS. CONCLUSIONS: A SIMPLIFIED YOGA-BASED REGIMEN IS A SAFE AND EFFECTIVE COMPLEMENTARY CLINICAL TREATMENT MODALITY FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING THE CLINICAL REMISSION PHASE. 2015 5 1400 34 IMPACT OF YOGA NIDRA ON PSYCHOLOGICAL GENERAL WELLBEING IN PATIENTS WITH MENSTRUAL IRREGULARITIES: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: YOGIC RELAXATION THERAPY (YOGA NIDRA) HAS BEEN EFFECTIVELY PRESCRIBED IN CONJUNCTION WITH OTHER MEDICAL AND YOGIC PROCEDURES IN THE MANAGEMENT OF SEVERE PSYCHOSOMATIC DISEASES, INCLUDING CANCER, BRONCHIAL ASTHMA, COLITIS, PEPTIC ULCER AND MENSTRUAL IRREGULARITIES. AIM OF THE STUDY: TO ASSESS THE IMPACT OF YOGA NIDRA ON PSYCHOLOGICAL PROBLEMS IN PATIENTS WITH MENSTRUAL DISORDERS. MATERIALS AND METHODS: PATIENTS WERE RECRUITED FROM THE DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, C.S.M. MEDICAL UNIVERSITY (ERSTWHILE KGMU), LUCKNOW, UTTAR PRADESH, INDIA. A TOTAL OF 150 FEMALE SUBJECTS WERE RANDOMLY DIVIDED INTO TWO GROUPS: 1) GROUP OF 75 SUBJECTS (WITH YOGIC INTERVENTION) AND 2) A CONTROL GROUP OF 75 SUBJECTS (WITHOUT YOGIC INTERVENTION). ASSESSMENT OF PSYCHOLOGICAL GENERAL WELLBEING (TOOL) WAS USED FOR ALL THE SUBJECTS ASSESSMENT OF PSYCHOLOGICAL GENERAL WELL BEING (TOOL) WAS USED FOR ALL THE SUBJECTS (CASES AND CONTROLS). THIS ASSESSMENT WAS DONE TWICE FIRST TIME IN THE BEGINNING (BASELINE) AND THEN AFTER SIX MONTHS. RESULTS: ANXIETY DECREASED SIGNIFICANTLY (P<0.003) AND DEPRESSION DECREASED SIGNIFICANTLY (P<0.01) IN THE YOGA GROUP. POSITIVE WELLBEING AND GENERAL HEALTH IMPROVED SIGNIFICANTLY (P<0.02), AND VITALITY IMPROVED SIGNIFICANTLY (P<0.01) AFTER SIX MONTHS OF YOGA THERAPY (YOGA NIDRA) IN THE YOGA GROUP COMPARED WITH THE CONTROL GROUP. CONCLUSION: THE CURRENT FINDINGS SUGGEST THAT PATIENTS WITH MENSTRUAL IRREGULARITIES HAVING PSYCHOLOGICAL PROBLEMS IMPROVED SIGNIFICANTLY IN THE AREAS OF THEIR WELLBEING, ANXIETY AND DEPRESSION BY LEARNING AND APPLYING A PROGRAM BASED ON YOGIC INTERVENTION (YOGA NIDRA). 2011 6 774 29 EFFECT OF YOGA AND NATUROPATHY ON DISEASE ACTIVITY AND SYMPTOM BURDENS IN A PATIENT WITH ACTIVE ULCERATIVE COLITIS: A CASE REPORT. OBJECTIVES: ULCERATIVE COLITIS (UC) IS A CHRONIC IDIOPATHIC INFLAMMATORY DISEASE THAT AFFECTS THE LARGE BOWEL. THE OBJECTIVE OF THIS STUDY IS TO FIND THE EFFECT OF YOGA AND NATUROPATHY (YN) IN A PATIENT WITH ACTIVE MODERATE PANCOLITIS. CASE PRESENTATION: AN 18-YEAR OLD UNMARRIED FEMALE DIAGNOSED WITH UC IN 2017. PATIENT'S SYMPTOMS BEGAN WITH ABDOMINAL PAIN, NAUSEA, VOMITING AND DIARRHEA WITH/WITHOUT BLOOD STAINS MORE THAN SEVEN TIMES A DAY, DAILY. THE SYMPTOMS REDUCED AFTER TAKING REGULAR CONVENTIONAL MEDICATION FOR A PERIOD OF ONE-YEAR. HOWEVER, IN FEBRUARY-2019, THE PATIENT VISITED OUR HOSPITAL WITH THE SAME COMPLAINTS AND RECEIVED 21-DAYS OF YN TREATMENTS. RESULTS SHOWED A BETTER REDUCTION IN THE ABDOMINAL PAIN, DISEASE ACTIVITY, STRESS AND DEPRESSION AND A BETTER IMPROVEMENT IN HEMOGLOBIN LEVELS, QUALITY OF SLEEP, AND QUALITY OF LIFE WITH NO ADVERSE EFFECTS. CONCLUSIONS: YN COULD BE CONSIDERED AS AN ALTERNATIVE THERAPY IN THE MANAGEMENT OF UC. HOWEVER, FURTHER STUDIES ARE REQUIRED TO WARRANT THIS EFFECT. 2021 7 2725 28 YOGA NIDRA AS A COMPLEMENTARY TREATMENT OF ANXIETY AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MENSTRUAL DISORDER. BACKGROUND: EMOTIONAL INSECURITY, STRESS, DEPRESSIVE OR/AND ANXIETY SYMPTOMS ARE COMMON WITH VARIABLE SEVERITY AMONG PATIENTS WITH MENSTRUAL DISORDER. YOGIC RELAXATION THERAPY (YOGA NIDRA) LEADS TO CONSCIOUS AND SUBCONSCIOUS RECOGNITION OF THESE UNDERLYING PSYCHOLOGICAL FACTORS AND HELPS RELEASING OF SUPPRESSED CONFLICTS. OBJECTIVE: TO EVALUATE THE EFFECT OF YOGA NIDRA ON ANXIETY AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MENSTRUAL DISORDERS. MATERIALS AND METHODS: SUBJECTS WERE RECRUITED FROM THE DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, C.S.M. MEDICAL UNIVERSITY (ERSTWHILE KGMU), LUCKNOW UTTAR PRADESH, INDIA. THE SUBJECTS WERE RANDOMLY DIVIDED IN TO TWO GROUPS: INTERVENTION GROUP (WITH YOGIC INTERVENTION) AND CONTROL GROUP (WITHOUT YOGIC INTERVENTION). ASSESSMENTS OF ALL SUBJECTS WERE CARRIED OUT BY ADMINISTERING HAMILTON ANXIETY SCALE (HAM-A) AND HAMILTON RATING SCALE FOR DEPRESSION (HAM-D) AT BASELINE AND AFTER SIX MONTHS. RESULTS: THE MEAN AGE WITH S.D OF THE INTERVENTION GROUP WAS 27.67 +/- 7.85 YEARS, AND FOR CONTROL GROUP WAS 26.58 +/- 6.87 YEARS (AMONG COMPLETED INTERVENTION GROUP NN = 65 AND CONTROL GROUP NN = 61). THERE WAS SIGNIFICANT REDUCTION OF SCORES IN HAM-A (P<0.003) AND HAM-D (P<0.02) RESPECTIVELY IN SUBJECTS WITH MILD TO MODERATE ANXIETY AND DEPRESSIVE SYMPTOMS AFTER SIX MONTHS OF YOGA THERAPY (YOGA NIDRA) IN INTERVENTION GROUP IN COMPARISON TO CONTROL GROUP. CONCLUSION: THE PATIENTS WITH MILD TO MODERATE ANXIETY AND DEPRESSIVE SYMPTOMS IMPROVE SIGNIFICANTLY WITH 'YOGA NIDRA' INTERVENTION. THERE IS NO SIGNIFICANT IMPROVEMENT IN THE PATIENTS WITH SEVERE ANXIETY AND DEPRESSIVE SYMPTOMS. 2012 8 1977 31 SIX-MONTH TRIAL OF YOGA NIDRA IN MENSTRUAL DISORDER PATIENTS: EFFECTS ON SOMATOFORM SYMPTOMS. BACKGROUND: YOGA NIDRA IS A SUCCESSFUL THERAPY FOR BOTH RECENT AND LONG-STANDING PSYCHOLOGICAL DISTURBANCES OF ALL KINDS ESPECIALLY DEPRESSION AND HIGH ANXIETY LEVEL AND NEUROTIC PATTERNS. OBJECTIVE: THE PURPOSE OF THE PRESENT WORK, THEREFORE, WAS TO CONDUCT A PRELIMINARY RANDOMIZED STUDY OF YOGA NIDRA AS A TREATMENT IN THE PATIENTS OF MENSTRUAL DISORDERS WITH SOMATOFORM SYMPTOMS. MATERIALS AND METHODS: PATIENTS WERE RECRUITED FROM DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, CSM MEDICAL UNIVERSITY (ERSTWHILE KGMU) LUCKNOW, UTTAR PRADESH, INDIA. ONE HUNDRED AND FIFTY FEMALE PATIENTS WITH MENSTRUAL DISORDERS WERE RANDOMLY DIVIDED IN TO TWO GROUPS 1- INTERVENTION GROUP: 75 SUBJECTS (YOGA NIDRA INTERVENTION AND MEDICATION) 2- CONTROL GROUP: 75 SUBJECTS (WITHOUT YOGA NIDRA INTERVENTION ONLY MEDICATION). SCHEDULE FOR CLINICAL ASSESSMENT IN NEUROPSYCHIATRY TOOL WAS USED. RESULTS: THERE WAS SIGNIFICANT IMPROVEMENT IN PAIN SYMPTOMS (P<0.006), GASTROINTESTINAL SYMPTOMS (P<0.04), CARDIOVASCULAR SYMPTOMS (P<0.02) AND UROGENITAL SYMPTOMS (P<0.005) AFTER 6 MONTHS OF YOGA NIDRA THERAPY IN INTERVENTION GROUP IN COMPARISON TO CONTROL GROUP. CONCLUSION: YOGA NIDRA APPEARS TO BE A PROMISING INTERVENTION FOR PSYCHOSOMATIC PROBLEMS. IT IS COST-EFFECTIVE AND EASY TO IMPLEMENT. THE RESULTS INDICATE THAT SOMATOFORM SYMPTOMS IN PATIENTS WITH MENSTRUAL DISORDER CAN BE DECREASED BY LEARNING AND APPLYING A PROGRAM BASED ON YOGIC INTERVENTION (YOGA NIDRA). 2011 9 61 35 A COMPREHENSIVE REVIEW OF YOGA RESEARCH IN 2020. OBJECTIVES: ACCUMULATED EVIDENCE GARNERED IN THE LAST FEW DECADES HAS HIGHLIGHTED THE ROLE OF YOGA IN HEALTH AND DISEASE. THE OVERWHELMING MORTALITY AND MORBIDITY MEDIATED BY NONCOMMUNICABLE EPIDEMICS SUCH AS HEART DISEASE AND CANCER HAVE FOSTERED A SEARCH FOR MECHANISMS TO ATTENUATE THEM. DESPITE OVERWHELMING SUCCESS IN ACUTE CARE, THE EFFICACY OF MODERN MEDICINES HAS BEEN LIMITED ON THIS FRONT. YOGA IS ONE OF THE INTEGRATIVE THERAPIES THAT HAS COME TO LIGHT AS HAVING A SUBSTANTIAL ROLE IN PREVENTING AND MITIGATING SUCH DISORDERS. IT THUS SEEMS TRITE TO ANALYZE AND DISCUSS THE RESEARCH ADVANCEMENTS IN YOGA FOR 2020. THE PRESENT REVIEW ATTEMPTS TO DISTILL RECENT RESEARCH HIGHLIGHTS FROM VOLUMINOUS LITERATURE GENERATED IN 2020. METHODS: THIS REVIEW WAS CONDUCTED ON THE ARTICLES PUBLISHED OR ASSIGNED TO AN ISSUE IN 2020. THE AUTHORS SEARCHED THE PUBMED DATABASE FOR CLINICAL STUDIES PUBLISHED IN THE ENGLISH LANGUAGE, USING YOGA (INCLUDING MEDITATION) AS THE INTERVENTION, AND HAVING AN ADEQUATE DESCRIPTION OF THE INTERVENTION. THEN, THEY EXTRACTED DATA FROM EACH STUDY INTO A STANDARDIZED GOOGLE SHEET. RESULTS: A TOTAL OF 1149 CITATIONS WERE RETRIEVED IN THE INITIAL SEARCH. OF THESE, 46 STUDIES MET ELIGIBILITY CRITERIA AND WERE FINALLY INCLUDED. THE STUDIES WERE PREDOMINANTLY ON MENTAL HEALTH AND NEUROPSYCHOLOGY, ADDRESSING VARIOUS ISSUES SUCH AS ANXIETY, POSTURAL BALANCE, MIGRAINE, ACADEMIC PERFORMANCE, AND CHILDHOOD NEGLECT. ANXIETY, STRESS, AND DEPRESSION WERE OTHER COMMON DENOMINATORS. EIGHT STUDIES WERE ON CARDIORESPIRATORY SYSTEMS, INCLUDING EXERCISE CAPACITY, CARDIAC REHABILITATION, MYOCARDIAL INFARCTION, AND HYPERTENSION. THREE STUDIES WERE ON DIABETES, EVALUATING THE EFFECT OF YOGA. FIVE STUDIES FOCUSED ON COGNITION, HEALTH STATUS, AND AUTONOMIC REGULATION AND FEW OTHERS INCLUDED CANCERS, INFERTILITY, ULCERATIVE COLITIS, URINARY INCONTINENCE, RESTLESS LEG SYNDROME, RHEUMATOID ARTHRITIS, CHRONIC PAIN, AND METABOLIC SYNDROME. FINALLY, MOST STUDIES WERE ON NONCOMMUNICABLE DISEASES WITH ONE EXCEPTION, HUMAN IMMUNODEFICIENCY VIRUS; TWO RANDOMIZED CONTROLLED TRIALS WERE DEDICATED TO IT. CONCLUSIONS: YOGA HAS BEEN STUDIED UNDER A WIDE VARIETY OF CLINICOPATHOLOGICAL CONDITIONS IN THE YEAR 2020. THIS LANDSCAPE REVIEW INTENDS TO PROVIDE AN IDEA OF THE ROLE OF YOGA IN VARIOUS CLINICAL CONDITIONS AND ITS FUTURE THERAPEUTIC IMPLICATIONS. 2022 10 783 31 EFFECT OF YOGA BASED LIFESTYLE INTERVENTION ON STATE AND TRAIT ANXIETY. CONSIDERABLE EVIDENCE EXISTS FOR THE PLACE OF MIND BODY MEDICINE IN THE TREATMENT OF ANXIETY DISORDERS. EXCESSIVE ANXIETY IS MALADAPTIVE. IT IS OFTEN CONSIDERED TO BE THE MAJOR COMPONENT OF UNHEALTHY LIFESTYLE THAT CONTRIBUTES SIGNIFICANTLY TO THE PATHOGENESIS OF NOT ONLY PSYCHIATRIC BUT ALSO MANY OTHER SYSTEMIC DISORDERS. AMONG THE APPROACHES TO REDUCE THE LEVEL OF ANXIETY HAS BEEN THE SEARCH FOR HEALTHY LIFESTYLES. THE AIM OF THE STUDY WAS TO STUDY THE SHORT-TERM IMPACT OF A COMPREHENSIVE BUT BRIEF LIFESTYLE INTERVENTION, BASED ON YOGA, ON ANXIETY LEVELS IN NORMAL AND DISEASED SUBJECTS. THE STUDY WAS THE RESULT OF OPERATIONAL RESEARCH CARRIED OUT IN THE INTEGRAL HEALTH CLINIC (IHC) AT THE DEPARTMENT OF PHYSIOLOGY OF ALL INDIA INSTITUTE OF MEDICAL SCIENCES. THE SUBJECTS HAD HISTORY OF HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS, OBESITY, PSYCHIATRIC DISORDERS (DEPRESSION, ANXIETY, 'STRESS'), GASTROINTESTINAL PROBLEMS (NON ULCER DYSPEPSIA, DUODENAL ULCERS, IRRITABLE BOWEL DISEASE, CROHN'S DISEASE, CHRONIC CONSTIPATION) AND THYROID DISORDERS (HYPERTHYROIDISM AND HYPOTHYROIDISM). THE INTERVENTION CONSISTED OF ASANAS, PRANAYAMA, RELAXATION TECHNIQUES, GROUP SUPPORT, INDIVIDUALIZED ADVICE, AND LECTURES AND FILMS ON PHILOSOPHY OF YOGA, THE PLACE OF YOGA IN DAILY LIFE, MEDITATION, STRESS MANAGEMENT, NUTRITION, AND KNOWLEDGE ABOUT THE ILLNESS. THE OUTCOME MEASURES WERE ANXIETY SCORES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. ANXIETY SCORES, BOTH STATE AND TRAIT ANXIETY WERE SIGNIFICANTLY REDUCED. AMONG THE DISEASED SUBJECTS SIGNIFICANT IMPROVEMENT WAS SEEN IN THE ANXIETY LEVELS OF PATIENTS OF HYPERTENSION, CORONARY ARTERY DISEASE, OBESITY, CERVICAL SPONDYLITIS AND THOSE WITH PSYCHIATRIC DISORDERS. THE OBSERVATIONS SUGGEST THAT A SHORT EDUCATIONAL PROGRAMME FOR LIFESTYLE MODIFICATION AND STRESS MANAGEMENT LEADS TO REMARKABLE REDUCTION IN THE ANXIETY SCORES WITHIN A PERIOD OF 10 DAYS. 2006 11 496 26 COMBINATION OF AYURVEDA AND YOGA THERAPY REDUCES PAIN INTENSITY AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH MIGRAINE HEADACHE. OBJECTIVES: TO UNDERSTAND THE EFFICACY OF AYURVEDA AND YOGA IN THE MANAGEMENT OF MIGRAINE HEADACHE. METHODS: 30 SUBJECTS RECRUITED TO AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATORY PROCESS) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NSAID'S) FOR 90 DAYS. BODY CONSTITUTION QUESTIONNAIRE WAS ADMINISTERED TO BOTH GROUPS. THE OUTCOME MEASURES INCLUDED SYMPTOM CHECK LIST, COMPREHENSIVE HEADACHE RELATED QUALITY OF LIFE QUESTIONNAIRE AND VISUAL ANALOGUE SCALE. RESULTS: FORTY-SIX (76.6%) OUT OF 60 SUBJECTS BELONGING TO BOTH GROUPS HAD PITTA BASED BODY CONSTITUTION. FOLLOWING 90 DAYS OF INTERVENTION THE AY GROUP SHOWED SIGNIFICANT REDUCTION IN MIGRAINE SYMPTOMS INCLUDING PAIN INTENSITY (P<.001) AND IMPROVEMENT IN HEADACHE RELATED QUALITY OF LIFE (P<.001). THE CT GROUP SHOWED NO SIGNIFICANT CHANGE (P>.05). CONCLUSION: TRADITIONAL AYURVEDA ALONG WITH YOGA THERAPY REDUCES SYMPTOMS, INTENSITY OF PAIN AND IMPROVES QUALITY OF LIFE IN MIGRAINE PATIENTS. 2018 12 508 33 COMPARATIVE EFFICACY OF A 12 WEEK YOGA-BASED LIFESTYLE INTERVENTION AND DIETARY INTERVENTION ON ADIPOKINES, INFLAMMATION, AND OXIDATIVE STRESS IN ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. THE PRESENT RANDOMIZED CONTROLLED TRIAL (RCT) EVALUATED THE COMPARATIVE EFFICACY OF 12 WEEK YOGA-BASED LIFESTYLE INTERVENTION (YBLI) AND DIETARY INTERVENTION (DI) ALONE ON ADIPOKINES, INFLAMMATION, AND OXIDATIVE STRESS IN INDIAN ADULTS WITH METABOLIC SYNDROME (MET S). A PARALLEL, TWO ARM, RCT WAS CONDUCTED IN INTEGRAL HEALTH CLINIC (IHC), ALL INDIA INSTITUTE OF MEDICAL SCIENCES, INDIA FROM 2012 TO 2014. IHC IS AN OUTPATIENT FACILITY CONDUCTING YBLI PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. TWO HUNDRED SIXTY MEN AND WOMEN (20-45 YEARS) VISITING THE OUTPATIENT DEPARTMENT OF A TERTIARY CARE HOSPITAL WERE DIAGNOSED WITH MET S AND RANDOMIZED 1:1 TO RECEIVE 12 WEEK YBLI (N = 130) OR DI (N = 130). PRIMARY OUTCOMES WERE CHANGE IN PLASMA LEVELS OF ADIPOKINES (LEPTIN, ADIPONECTIN, AND LEPTIN:ADIPONECTIN RATIO), MARKERS OF INFLAMMATION (TUMOR NECROSIS FACTOR [TNF]-ALPHA, INTERLEUKIN [IL]-6), MARKERS OF OXIDATIVE STRESS (THIOBARBITURIC ACID REACTIVE SUBSTANCES [TBARS], 8-HYDROXY-2'-DEOXYGUANOSINE [8-OHDG], AND SUPEROXIDE DISMUTASE [SOD]) MEASURED AT BASELINE, 2 WEEKS, AND 12 WEEKS. YBLI GROUP SHOWED A SIGNIFICANT DECREASE IN LEPTIN, LEPTIN:ADIPONECTIN RATIO, IL-6, 8-OHDG, AND TBARS LEVELS, WHEREAS THERE WAS A SIGNIFICANT INCREASE IN ADIPONECTIN AND SOD LEVELS. NO SIGNIFICANT CHANGES WERE NOTICED IN DI ALONE GROUP. YBLI SHOWED SIGNIFICANTLY GREATER REDUCTION IN TBARS LEVELS THAN IN DI GROUP, SUGGESTIVE OF REDUCED OXIDATIVE STRESS IN ADULTS WITH MET S. A 12 WEEK YBLI HAD A POSITIVE IMPACT ON OXIDATIVE STRESS VERSUS DI ALONE IN ADULTS WITH MET S. 2019 13 867 36 EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: LUNG FUNCTIONS ARE FOUND TO BE IMPAIRED IN CORONARY ARTERY DISEASE (CAD), CONGESTIVE HEART FAILURE, LEFT VENTRICULAR DYSFUNCTION, AND AFTER CARDIAC SURGERY. DIFFUSION CAPACITY PROGRESSIVELY WORSENS AS THE SEVERITY OF CAD INCREASES DUE TO REDUCTION IN LUNG TISSUE PARTICIPATING IN GAS EXCHANGE. AIMS AND OBJECTIVES: PRANAYAMA BREATHING EXERCISES AND YOGIC POSTURES MAY PLAY AN IMPRESSIVE ROLE IN IMPROVING CARDIO-RESPIRATORY EFFICIENCY AND FACILITATING GAS DIFFUSION AT THE ALVEOLO-CAPILLARY MEMBRANE. THIS STUDY WAS DONE TO SEE THE EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS PARTICULARLY DIFFUSION CAPACITY IN CAD PATIENTS. MATERIALS AND METHODS: A TOTAL OF 80 STABLE CAD PATIENTS BELOW 65 YEARS OF AGE OF BOTH SEXES WERE SELECTED AND RANDOMIZED INTO TWO GROUPS OF 40 EACH. GROUP I CAD PATIENTS WERE GIVEN YOGA REGIMEN FOR 3 MONTHS WHICH CONSISTED OF YOGIC POSTURES, PRANAYAMA BREATHING EXERCISES, DIETARY MODIFICATION, AND HOLISTIC TEACHING ALONG WITH THEIR CONVENTIONAL MEDICINE WHILE GROUP II CAD PATIENTS WERE PUT ONLY ON CONVENTIONAL MEDICINE. LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY WERE RECORDED THRICE IN BOTH THE GROUPS: 0 DAY AS BASELINE, 22(ND) DAY AND ON 90(TH) DAY BY USING COMPUTERIZED MS MEDISOFT CARDIO-RESPIRATORY INSTRUMENT, HYP'AIR COMPACT MODEL OF CARDIO-RESPIRATORY TESTING MACHINE WAS MANUFACTURED BY P K MORGAN, INDIA. THE RECORDED PARAMETERS WERE STATISTICALLY ANALYZED BY REPEATED MEASURES ANOVA FOLLOWED BY TUKEY'S TEST IN BOTH THE GROUPS. CARDIOVASCULAR PARAMETERS WERE ALSO COMPARED BEFORE AND AFTER INTERVENTION IN BOTH THE GROUPS. RESULTS: STATISTICALLY SIGNIFICANT IMPROVEMENTS WERE SEEN IN SLOW VITAL CAPACITY, FORCED VITAL CAPACITY, PEAK EXPIRATORY FLOW RATE, MAXIMUM VOLUNTARY VENTILATION, AND DIFFUSION FACTOR/ TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE AFTER 3 MONTHS OF YOGA REGIMEN IN GROUP I. FORCED EXPIRATORY VOLUME IN 1(ST) SEC (FEV1), AND FEV1 % ALSO SHOWED A TREND TOWARD IMPROVEMENT ALTHOUGH NOT STATISTICALLY SIGNIFICANT. HR, SBP AND DBP ALSO SHOWED SIGNIFICANT IMPROVEMENT IN GROUP-I PATIENTS WHO FOLLOWED YOGA REGIMEN. CONCLUSIONS: YOGA REGIMEN WAS FOUND TO IMPROVE LUNG FUNCTIONS AND DIFFUSION CAPACITY IN CAD PATIENTS BESIDES IMPROVING CARDIOVASCULAR FUNCTIONS. THUS, IT CAN BE USED AS A COMPLIMENTARY OR ADJUNCT THERAPY ALONG WITH THE CONVENTIONAL MEDICINE FOR THEIR TREATMENT AND REHABILITATION. 2015 14 353 29 ASSESSMENT OF THE QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA, BEFORE AND AFTER YOGA: A RANDOMISED TRIAL. YOGA WHICH IS USED AS AN ADJUNCT TREATMENT FOR BRONCHIAL ASTHMA IS GAINING POPULARITY THROUGHOUT THE WORLD. THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFECT OF YOGA ON QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA. 120 NON-SMOKING MALE AND FEMALE PATIENTS OF ASTHMA IN THE AGE GROUP OF 17-50 YEARS WERE RANDOMIZED INTO TWO GROUPS I.E. GROUP A (YOGA GROUP) AND GROUP B (CONTROL GROUP). ALL PATIENTS REMAINED ON THEIR PRESCRIBED MEDICATION, BUT GROUP A PATIENTS PRACTICED YOGA BREATHING EXERCISES FOR 8 WEEKS. ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) AND DIARY RECORD WAS USED TO ASSESS QUALITY OF LIFE, NUMBER AND SEVERITY OF ASTHMATIC ATTACKS, AND THE DOSAGE OF THE MEDICATION REQUIRED AT BASELINE AND AFTER 8 WEEKS. GROUP A SUBJECTS SHOWED A STATISTICALLY SIGNIFICANT IMPROVEMENT IN "SYMPTOMS", "ACTIVITIES" AND "ENVIRONMENTAL" DOMAINS OF AQLQ AT 8 WEEKS (P<0.01) AND SIGNIFICANT REDUCTION IN DAILY NUMBER AND SEVERITY OF ATTACKS, AND THE DOSAGE OF MEDICATION REQUIRED AT 4 AND 8 WEEKS (P<0.01) COMPARED TO THE BASELINE. YOGA BREATHING EXERCISES USED ADJUNCTIVELY WITH STANDARD PHARMACOLOGICAL TREATMENT SIGNIFICANTLY IMPROVED QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA. 2014 15 1904 37 RETARDATION OF CORONARY ATHEROSCLEROSIS WITH YOGA LIFESTYLE INTERVENTION. BACKGROUND: YOGA HAS POTENTIAL FOR BENEFIT FOR PATIENTS WITH CORONARY ARTERY DISEASE THOUGH OBJECTIVE, ANGIOGRAPHIC STUDIES ARE LACKING. MATERIAL AND METHODS: WE EVALUATED POSSIBLE ROLE OF LIFESTYLE MODIFICATION INCORPORATING YOGA, ON RETARDATION OF CORONARY ATHEROSCLEROTIC DISEASE. IN THIS PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL, 42 MEN WITH ANGIOGRAPHICALLY PROVEN CORONARY ARTERY DISEASE (CAD) WERE RANDOMIZED TO CONTROL (N = 21) AND YOGA INTERVENTION GROUP (N = 21) AND WERE FOLLOWED FOR ONE YEAR. THE ACTIVE GROUP WAS TREATED WITH A USER-FRIENDLY PROGRAM CONSISTING OF YOGA, CONTROL OF RISK FACTORS, DIET CONTROL AND MODERATE AEROBIC EXERCISE. THE CONTROL GROUP WAS MANAGED BY CONVENTIONAL METHODS I.E. RISK FACTOR CONTROL AND AMERICAN HEART ASSOCIATION STEP I DIET. RESULTS: AT ONE YEAR, THE YOGA GROUPS SHOWED SIGNIFICANT REDUCTION IN NUMBER OF ANGINAL EPISODES PER WEEK, IMPROVED EXERCISE CAPACITY AND DECREASE IN BODY WEIGHT. SERUM TOTAL CHOLESTEROL, LDL CHOLESTEROL AND TRIGLYCERIDE LEVELS ALSO SHOWED GREATER REDUCTIONS AS COMPARED WITH CONTROL GROUP. REVASCULARISATION PROCEDURES (CORONARY ANGIOPLASTY OR BYPASS SURGERY) WERE LESS FREQUENTLY REQUIRED IN THE YOGA GROUP (ONE VERSUS EIGHT PATIENTS; RELATIVE RISK = 5.45; P = 0.01). CORONARY ANGIOGRAPHY REPEATED AT ONE YEAR SHOWED THAT SIGNIFICANTLY MORE LESIONS REGRESSED (20% VERSUS 2%) AND LESS LESIONS PROGRESSED (5% VERSUS 37%) IN THE YOGA GROUP (CHI-SQUARE = 24.9; P < 0.0001). THE COMPLIANCE TO THE TOTAL PROGRAM WAS EXCELLENT AND NO SIDE EFFECTS WERE OBSERVED. CONCLUSION: YOGA LIFESTYLE INTERVENTION RETARDS PROGRESSION AND INCREASES REGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH SEVERE CORONARY ARTERY DISEASE. IT ALSO IMPROVES SYMPTOMATIC STATUS, FUNCTIONAL CLASS AND RISK FACTOR PROFILE. 2000 16 1035 25 EFFECTS OF YOGA IN INFLAMMATORY BOWEL DISEASES AND ON FREQUENT IBD-ASSOCIATED EXTRAINTESTINAL SYMPTOMS LIKE FATIGUE AND DEPRESSION. QUALITY OF LIFE (QOL) OF PERSONS WITH INFLAMMATORY BOWEL DISEASES (IBD) IS OFTEN IMPAIRED BY SYMPTOMS THAT DO NOT PRIMARILY RELATE TO INTESTINAL INFLAMMATION. AMONG THE MOST CHALLENGING EXTRAINTESTINAL SYMPTOMS ARE DEPRESSION AND FATIGUE, WHICH ARE ALSO FREQUENT IN OTHER CHRONIC DISEASES LIKE MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND CANCER. YOGA AS AN ANCIENT INDIAN TRADITION CONTAINING POSTURES, BREATHING EXERCISES AND MEDITATION MAY POSITIVELY INFLUENCE THOSE SYMPTOMS. THIS REVIEW EVALUATES THE CURRENT LITERATURE WITH REGARD TO THE EFFECT OF YOGA-BASED INTERVENTIONS IN PERSONS WITH IBD AND WITH REGARD TO QOL, DEPRESSION AND FATIGUE IN OTHER SOMATIC DISORDERS. A SYSTEMATIC LITERATURE SEARCH YIELDED THREE TRIALS EXAMINING THE EFFECTS OF YOGA IN PATIENTS WITH IBD AND 37 TRIALS ADDRESSING DEPRESSIVE SYNDROMES OR FATIGUE IN SOMATIC DISORDERS. IN SUMMARY, BOTH IN-PERSON AND VIDEO-BASED YOGA CLASSES ARE FEASIBLE, ACCEPTABLE AND SAFE AS COMPLEMENTARY TREATMENT IN PATIENTS WITH IBD AND SIGNIFICANTLY IMPROVE ANXIETY AND IMPAIRED QUALITY OF LIFE. CURRENT LITERATURE DOES NOT PROVIDE INFORMATION ON THE EFFECT OF YOGA ON DEPRESSION AND FATIGUE IN PATIENTS WITH IBD, BUT RESEARCH FROM OTHER SOMATIC DISORDERS OR PATIENTS WITH DEPRESSIVE DISORDERS IMPLIES THE POTENTIAL OF YOGA IN THIS REGARD FOR PERSONS WITH IBD. THIS SHOULD BE SPECIFICALLY ADDRESSED IN INTERVENTIONAL TRIALS WITH STANDARDIZED YOGA MODULES INCLUDING PATIENTS WITH IBD SUFFERING FROM FATIGUE, DEPRESSION AND/OR IMPAIRED QOL. 2021 17 831 41 EFFECT OF YOGA ON MIGRAINE: A COMPREHENSIVE STUDY USING CLINICAL PROFILE AND CARDIAC AUTONOMIC FUNCTIONS. CONTEXT AND AIMS: MIGRAINE IS AN EPISODIC DISABLING HEADACHE REQUIRING LONG-TERM MANAGEMENT. MIGRAINE MANAGEMENT THROUGH YOGA THERAPY WOULD REDUCE THE MEDICATION COST WITH POSITIVE HEALTH BENEFITS. YOGA HAS SHOWN TO IMPROVE THE QUALITY OF LIFE, REDUCE THE EPISODE OF HEADACHE AND MEDICATION. THE AIM OF THE PRESENT STUDY WAS TO EVALUATE THE EFFICACY OF YOGA AS AN ADJUVANT THERAPY IN MIGRAINE PATIENTS BY ASSESSING CLINICAL OUTCOME AND AUTONOMIC FUNCTIONS TESTS. SUBJECTS AND METHODS: MIGRAINE PATIENTS WERE RANDOMLY GIVEN EITHER CONVENTIONAL CARE (N = 30) OR YOGA WITH CONVENTIONAL CARE (N = 30). YOGA GROUP RECEIVED YOGA PRACTICE SESSION FOR 5 DAYS A WEEK FOR 6 WEEKS ALONG WITH CONVENTIONAL CARE. CLINICAL ASSESSMENT (FREQUENCY, INTENSITY OF HEADACHE AND HEADACHE IMPACT) AND AUTONOMIC FUNCTION TEST WERE DONE AT BASELINE AND AT THE END OF THE INTERVENTION. RESULTS: YOGA WITH CONVENTIONAL CARE AND CONVENTION CARE GROUPS SHOWED SIGNIFICANT IMPROVEMENT IN CLINICAL VARIABLES, BUT IT WAS BETTER WITH YOGA THERAPY. IMPROVEMENT IN THE VAGAL TONE ALONG WITH REDUCED SYMPATHETIC ACTIVITY WAS OBSERVED IN PATIENTS WITH MIGRAINE RECEIVING YOGA AS ADJUVANT THERAPY. CONCLUSIONS: INTERVENTION SHOWED SIGNIFICANT CLINICAL IMPROVEMENT IN BOTH GROUPS. HEADACHE FREQUENCY AND INTENSITY WERE REDUCED MORE IN YOGA WITH CONVENTIONAL CARE THAN THE CONVENTIONAL CARE GROUP ALONE. FURTHERMORE, YOGA THERAPY ENHANCED THE VAGAL TONE AND DECREASED THE SYMPATHETIC DRIVE, HENCE IMPROVING THE CARDIAC AUTONOMIC BALANCE. THUS, YOGA THERAPY CAN BE EFFECTIVELY INCORPORATED AS AN ADJUVANT THERAPY IN MIGRAINE PATIENTS. 2014 18 959 26 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013 19 793 44 EFFECT OF YOGA IN THE THERAPY OF IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW. BACKGROUND & AIMS: THIS REVIEW AIMS TO SYSTEMATICALLY SURVEY THE EFFECTS OF YOGA ON SYMPTOMS OF IRRITABLE BOWEL SYNDROME (IBS), PAIN, QUALITY OF LIFE, MOOD, STRESS, AND SAFETY IN PATIENTS WITH IBS. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, CAM-QUEST, CAMBASE, AND INDMED WERE SCREENED THROUGH NOVEMBER 2015. RANDOMIZED CONTROLLED TRIALS COMPARING YOGA WITH USUAL CARE, NONPHARMACOLOGIC, OR PHARMACOLOGIC INTERVENTIONS WERE ANALYZED FOR PATIENTS WITH IBS. PRIMARY OUTCOMES INCLUDED GASTROINTESTINAL SYMPTOMS, QUALITY OF LIFE, AND PAIN. ANXIETY, MOOD, AND SAFETY WERE DEFINED AS SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED ACCORDING TO THE COCHRANE COLLABORATION RECOMMENDATIONS. RESULTS: SIX RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 273 PATIENTS WERE INCLUDED IN THE QUALITATIVE ANALYSIS. THERE WAS EVIDENCE FOR A BENEFICIAL EFFECT OF A YOGIC INTERVENTION OVER CONVENTIONAL TREATMENT IN IBS, WITH SIGNIFICANTLY DECREASED BOWEL SYMPTOMS, IBS SEVERITY, AND ANXIETY. FURTHERMORE, THERE WERE SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, GLOBAL IMPROVEMENT, AND PHYSICAL FUNCTIONING AFTER YOGA COMPARED WITH NO TREATMENT. TWO RANDOMIZED CONTROLLED TRIALS REPORTED SAFETY DATA STATING THAT NO ADVERSE EVENTS OCCURRED. OVERALL, RISK OF BIAS OF THE INCLUDED STUDIES WAS UNCLEAR. CONCLUSIONS: THE FINDINGS OF THIS SYSTEMATIC REVIEW SUGGEST THAT YOGA MIGHT BE A FEASIBLE AND SAFE ADJUNCTIVE TREATMENT FOR PEOPLE WITH IBS. NEVERTHELESS, NO RECOMMENDATION CAN BE MADE REGARDING YOGA AS A ROUTINE INTERVENTION FOR PATIENTS WITH IBS BECAUSE OF MAJOR FLAWS IN STUDY METHODS. MORE RESEARCH IS NEEDED WITH RESPECT TO A HIGH-QUALITY STUDY DESIGN AND CONSENSUS IN CLINICAL OUTCOME MEASUREMENTS IN IBS. CLINICALTRIALS.GOV NUMBER, NCT02721836. 2016 20 1675 21 OBESITY-RELATED INFLAMMATION & CARDIOVASCULAR DISEASE: EFFICACY OF A YOGA-BASED LIFESTYLE INTERVENTION. OBESITY IS A GLOBAL HEALTH BURDEN AND ITS PREVALENCE IS INCREASING SUBSTANTIALLY DUE TO CHANGING LIFESTYLE. CHRONIC ADIPOSITY IS ASSOCIATED WITH METABOLIC IMBALANCE LEADING TO DYSLIPIDAEMIA, DIABETES, HYPERTENSION AND CARDIOVASCULAR DISEASES (CVD). ADIPOSE TISSUE ACTS AS AN ENDOCRINE ORGAN RELEASING SEVERAL ADIPOCYTOKINES, AND IS ASSOCIATED WITH INCREASED LEVELS OF TISSUE AND CIRCULATING INFLAMMATORY BIOMOLECULES CAUSING VASCULAR INFLAMMATION AND ATHEROGENESIS. FURTHER, INFLAMMATION IS ALSO ASSOCIATED INDEPENDENTLY WITH OBESITY AS WELL AS CVD. KEEPING THIS IN VIEW, IT IS POSSIBLE THAT A REDUCTION IN WEIGHT MAY LEAD TO A DECREASE IN INFLAMMATION, RESULTING IN CVD RISK REDUCTION, AND BETTER MANAGEMENT OF PATIENTS WITH CVD. LIFESTYLE INTERVENTION HAS BEEN ENDORSED BY SEVERAL HEALTH AUTHORITIES IN PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. A YOGA-BASED LIFESTYLE INTERVENTION APPEARS TO BE A PROMISING OPTION IN REDUCING THE RISK FOR CVD AS WELL AS MANAGEMENT OF PATIENTS WITH CVD AS IT IS SIMPLE TO FOLLOW AND COST-EFFECTIVE WITH HIGH COMPLIANCE. THE EFFICACY OF SUCH LIFESTYLE INTERVENTION PROGRAMMES IS MULTIFACETED, AND IS ACHIEVED VIA REDUCTION IN WEIGHT, OBESITY-RELATED INFLAMMATION AND STRESS, THEREBY CULMINATING INTO RISK REDUCTION TOWARDS SEVERAL CHRONIC DISEASES INCLUDING CVD. IN THIS REVIEW, THE ASSOCIATION BETWEEN OBESITY-RELATED INFLAMMATION AND CVD, AND THE ROLE OF YOGA-BASED LIFESTYLE INTERVENTION IN PREVENTION AND MANAGEMENT OF CVD ARE DISCUSSED. 2014